Related Experiment Video
Updated: Jun 18, 2026
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
1.8K
Lessons from IgA Nephropathy Models.
Toshiki Kano1, Hitoshi Suzuki1,2, Yuko Makita1
1Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
International Journal of Molecular Sciences
|November 9, 2024
Summary
Animal models reveal IgA nephropathy (IgAN) pathogenesis involves aberrant IgA1 glycosylation and immune complex formation. These models guide the development of targeted therapies for IgAN patients.
Area of Science:
- Nephrology
- Immunology
- Pathogenesis Research
Background:
- IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis globally.
- The precise mechanisms driving IgAN pathogenesis remain incompletely understood.
- Aberrant glycosylation of immunoglobulin A1 (IgA1) and immune complex formation are implicated in IgAN.
Purpose of the Study:
- To review and analyze various animal models used to study IgAN pathogenesis.
- To highlight the insights gained from these models regarding IgAN development and progression.
- To connect findings from animal models to ongoing clinical trials and therapeutic strategies.
Main Methods:
- Exploration of spontaneous, immunization, and transgenic animal models of IgAN.
- Analysis of the grouped ddY (gddY) mouse model as a representation of multi-hit pathogenesis.
- Review of clinical trial data targeting molecular pathways in IgAN, such as APRIL.
Main Results:
- Animal models elucidate the multi-hit pathogenesis of IgAN, involving genetic and environmental factors.
- These models demonstrate how dysregulated mucosal immunity leads to aberrant IgA1 glycosylation and nephritogenic immune complex formation.
- Glomerular deposition of immune complexes triggers mesangial cell activation and injury.
Conclusions:
- Animal models have significantly advanced the understanding of IgAN pathogenesis.
- Insights from animal studies are instrumental in developing novel therapeutic strategies for IgAN.
- Model-based research holds promise for creating targeted IgAN therapies with improved safety profiles.
Related Concept Videos
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...